Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 4, 1997, Pages 372-376

  Leach, John Paul ^a   Girvan, Jacqueline ^a   Paul, Audrey ^a   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Cognition; Epilepsy; Gabapentin

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DYSPHORIA; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MEMORY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030940881     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.4.372     Document Type: Article

References (20)

1. Chadwick D. Gabapemin. Lancet 1994;343:89-91.
2. McLean MJ. Gabapentin. Epilepsia 1995;36(suppl 2): 73-86.
3. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335:1114-7.
4. US Gabapentin Study Group. Gabapentin as add-on therapy in refractory epilepsy: a double-blind, placebo-controlled, parallel group study. Neurology 1993;43:2292-8.
5. Anhut H, Ashman P, Feuerstein TJ, et al. Gabapentin as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994;35: 795-801.
6. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-90.
7. Brodie MJ, McPhail E, Macphee GJA, Larkin JG, Gray JMB. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients. Eur J Clin Pharmacol 1987; 31:655-60.
8. Gillham RA, Williams N, Wiedmann KD, Butler E, Larkin JG, Brodie MJ. Concentration effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. J Neurol Neurosurg Psychiatry 1988;51:929-33.
9. Gillham RA, Williams N, Wiedmann KD, Butler E, Larkin JG, Brodie MJ. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res 1990;7:219-25
10. Gillham RA, Read CL, McKee PJW, Larkin JG, Brodie MJ. Cognitive function in adult epileptic patients on long-term sodium valproate. J Epilepsy 1991;4:205-10.
11. Gillham RA, Blacklaw J, McKee PJW, Brodie MJ. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1993;56:1271-5.
12. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.
13. Kalviainen R, Aikia M, Riekkinen PJ. Cognitive adverse effects of antiepileptic drugs. CNS Drugs 1996;5:358-68.
14. Brown SW, Tomlinson LL. Anticonvulsant side-effects: a self-report questionnaire for use in community surveys. Br J Clin Pract 1984;(suppl 18):147-9.
15. McKee PJW, Blacklaw J, Friel E, Thompson GG, Gillham RA, Brodie MJ. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients? Epilepsia 1993;34:937-43.
16. Kilpatrick ES, Forrest G, Brodie MJ. Concentration-effect-toxicity relationships with lamotrigine - a prospective study. Epilepsia 1996;37:534-8.
17. Forrest G, Sills GJ, Leach JP, Brodie MJ. Determination of gabapentin in plasma by high performance liquid chromatography. J Chromatogr B Biomed Appl 1996;681: 421-5.
18. Hooper WE, Kavanagh MC, Herkes GK, Eadie MJ. Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin. Br J Clin Pharmacol 1991;529:167-74.
19. Radulovic LL, Wilder BJ, Leppik IE, et al. Lack of interaction of gabapentin with carbamazepine or valproate. Epilepsia 1994;35:155-61.
20. Larkin JG, McKee PJW, Brodie MJ. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients. Br J Clin Pharmacol 1992;33:111-4.